154 related articles for article (PubMed ID: 26517961)
1. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
Chen CC; Chen YY; Lo YH; Lin MH; Chang CH; Chen CL; Wang HE; Wu CY
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916962
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
[TBL] [Abstract][Full Text] [Related]
7. Targeted radiotherapy of pigmented melanoma with
Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma.
Ballard B; Jiang Z; Soll CE; Revskaya E; Cutler CS; Dadachova E; Francesconi LC
Cancer Biother Radiopharm; 2011 Oct; 26(5):547-56. PubMed ID: 21970319
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
14. [¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.
Viallard C; Perrot Y; Boudhraa Z; Jouberton E; Miot-Noirault E; Bonnet M; Besse S; Mishellany F; Cayre A; Maigne L; Rbah-Vidal L; D'Incan M; Cachin F; Chezal JM; Degoul F
Eur J Dermatol; 2015; 25(1):29-35. PubMed ID: 25548082
[TBL] [Abstract][Full Text] [Related]
15. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
Semnani ES; Wang K; Adelstein SJ; Kassis AI
J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
[TBL] [Abstract][Full Text] [Related]
16. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents.
Roberts MP; Nguyen V; Ashford ME; Berghofer P; Wyatt NA; Krause-Heuer AM; Pham TQ; Taylor SR; Hogan L; Jiang CD; Fraser BH; Lengkeek NA; Matesic L; Gregoire MC; Denoyer D; Hicks RJ; Katsifis A; Greguric I
J Med Chem; 2015 Aug; 58(15):6214-24. PubMed ID: 26177000
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
[TBL] [Abstract][Full Text] [Related]
19. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
Bonnet-Duquennoy M; Papon J; Mishellany F; Labarre P; Guerquin-Kern JL; Wu TD; Gardette M; Maublant J; Penault-Llorca F; Miot-Noirault E; Cayre A; Madelmont JC; Chezal JM; Moins N
Int J Cancer; 2009 Aug; 125(3):708-16. PubMed ID: 19437532
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner R; Wester HJ; Reuning U; Senekowitsch-Schmidtke R; Diefenbach B; Kessler H; Stöcklin G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):1061-71. PubMed ID: 10452325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
